Tag: AbCelleras

Latest News

AbCellera’s Rapid Pandemic Response Platform Contributes to the World’s First COVID-19 Clinical Trial for a Potential Monoclonal Antibody Treatment

VANCOUVER, British Columbia–(BUSINESS WIRE)– #AbCellera–LY-CoV555, the lead antibody from the AbCellera and Lilly collaboration, has entered into human testing for the potential treatment of COVID-19....

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World